Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1)

European Journal of Surgical Oncology

Volumn 41, Issue 6, 2015, Pages 795-800

  Namikawa, T ^a   Fukudome, I ^a   Ogawa, M ^a   Munekage, E ^a   Munekage, M ^a   Shiga, M ^a   Maeda, H ^a   Kitagawa, H ^a   Kobayashi, M ^a   Hanazaki, K ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Gastric cancer; Immunochemotherapy; Neutrophil to lymphocyte ratio; Oral fluorouracil anticancer drug; Protein bound polysaccharide K

Indexed keywords

FLUOROPYRIMIDINE; KRESTIN; ANTINEOPLASTIC AGENT; DRUG COMBINATION; FUNGAL PROTEIN; OTERACIL; POLYSACCHARIDE; PROTEIN-BOUND POLYSACCHARIDE K, BASIDIOMYCETES; S 1 (COMBINATION); TEGAFUR;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN BINDING; RETROSPECTIVE STUDY; STOMACH CANCER; ADENOCARCINOMA; BLOOD; DRUG COMBINATION; IMMUNOLOGY; IMMUNOTHERAPY; KAPLAN MEIER METHOD; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; NEUTROPHIL; STOMACH NEOPLASMS; SURVIVAL RATE; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG COMBINATIONS; FEMALE; FUNGAL PROTEINS; HUMANS; IMMUNOTHERAPY; KAPLAN-MEIER ESTIMATE; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; OXONIC ACID; POLYSACCHARIDES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR;

EID: 84929129084     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.02.012     Document Type: Article

References (23)

1. F. Kamangar, G.M. Dores, and W.F. Anderson Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 14 2006 2137 2150
2. A. Jemal, M.M. Center, C. DeSantis, and E.M. Ward Global patterns of cancer incidence and mortality rates and trends Cancer Epidemiol Biomarkers Prev 19 8 2010 1893 1907
3. S. Sakuramoto, M. Sasako, and T. Yamaguchi Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 18 2007 1810 1820
4. W. Koizumi, H. Narahara, and T. Hara S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 3 2008 215 221
5. Y. Maehara, S. Tsujitani, and H. Saeki Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN): review of development and future perspectives Surg Today 42 1 2012 8 28
6. G. Ito, H. Tanaka, and M. Ohira Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I Exp Ther Med 3 6 2012 925 930
7. J. Sakamoto, S. Teramukai, A. Koike, S. Saji, Y. Ohashi, and H. Nakazato Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer Cancer 77 11 1996 2206 2212
8. M. Aliustaoglu, A. Bilici, and B.B. Ustaalioglu The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment Med Oncol 27 4 2010 1060 1065
9. T. Yamanaka, S. Matsumoto, S. Teramukai, R. Ishiwata, Y. Nagai, and M. Fukushima The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer Oncology 73 3-4 2007 215 220
10. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumours 7th ed. 2009 Wiley-Blackwell New York
11. C. Wittekind, F. Greene, R.V.P. Hutter, L.H. Sobin, and D.E. Henson TNM supplement: a commentary on uniform use 3rd ed. 2003 Wiley-Liss New York
12. S. Saji, J. Sakamoto, and S. Teramukai Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer Surg Today 29 6 1999 504 510
13. H. Asai, H. Iijima, K. Matsunaga, Y. Oguchi, H. Katsuno, and K. Maeda Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling Cancer Immunol Immunother 57 11 2008 1647 1655
14. H. Tanaka, K. Muguruma, and M. Ohira Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer Anticancer Res 32 8 2012 3427 3433
15. K. Oba, S. Teramukai, M. Kobayashi, T. Matsui, Y. Kodera, and J. Sakamoto Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer Cancer Immunol Immunother 56 6 2007 905 911
16. H. Nakazato, A. Koike, S. Saji, N. Ogawa, and J. Sakamoto Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer Lancet 343 8906 1994 1122 1126
17. H. Shimada, N. Takiguchi, and O. Kainuma High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer Gastric Cancer 13 3 2010 170 176
18. M.R. Jung, Y.K. Park, and O. Jeong Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer J Surg Oncol 104 5 2011 504 510
19. M. Hirashima, S. Higuchi, K. Sakamoto, T. Nishiyama, and H. Okada The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer J Cancer Res Clin Oncol 124 6 1998 329 334
20. W. Chua, K.A. Charles, V.E. Baracos, and S.J. Clarke Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer Br J Cancer 104 8 2011 1288 1295
21. T. Toge, and Y. Yamaguchi Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count Oncol Rep 7 5 2000 1157 1161
22. H. Jin, G. Zhang, and X. Liu Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy World J Surg Oncol 11 2013 112
23. T. Namikawa, I. Fukudome, H. Kitagawa, T. Okabayashi, M. Kobayashi, and K. Hanazaki Plasma diamine oxidase activity is a useful biomarker for evaluating gastrointestinal tract toxicities during chemotherapy with oral fluorouracil anti-cancer drugs in patients with gastric cancer Oncology 82 3 2012 147 152